Long-term open-label extension (OLE) study evaluating USL255, once-daily extended-release topiramate, in patients with partial onset seizures: Interim analysis from prevail OLE

Authors
Category Primary study
JournalNeurology
Year 2014
This article has no abstract
Epistemonikos ID: 6a1af2f89035a414b5a2cedcade5301e4bad1449
First added on: Feb 06, 2025